SLx-2119(KD-025,Belumosudil ) chemical structure
Chemical structureResearch use only
CAT. NO. DC8329Featured

SLx-2119(KD-025,Belumosudil )

Pack Sizes & Prices

TotalUS$300
We match the best price and quality on market.
Product overview

Description & Application

SLx-2119 is a selective inhibitor of ROCK2 with an IC50 of 105 nM.

ParameterValue
Chemical NameSLx-2119
CAS No.911417-87-3
SynonymsSLx2119(KD025)，SLx 2119(KD 025)，SLx2119，KD025
FormulaC26H24N6O2
M.Wt452.518
SMILESO=C(C([H])([H])OC1=C([H])C([H])=C([H])C(C2=NC3=C([H])C([H])=C([H])C([H])=C3C(N([H])C(C([H])=C4[H])=C([H])C5=C4N([H])N=C5[H])=N2)=C1[H])N([H])C(C([H])([H])[H])([H])C([H])([H])[H]
Purity>98%
Storage2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Biological Activity

SLx-2119 is a selective inhibitor of ROCK2 with an IC50 of 105 nM.

In Vitro

SLx-2119 (40 µM) induces significant down-regulations of Tsp-1 and CTGF mRNA levels in PASMC. The microarray hybridized with aRNA from HMVEC treated with SLx-2119, shows a 5-times higher background than the other arrays[1].

In Vivo

KD025 (100, 200 or 300 mg/kg, i.p.) dose-dependently reduces infarct volume after transient middle cerebral artery occlusion. KD025 is at least as efficacious in aged, diabetic or female mice, as in normal adult males[2].

References & source

DC Chemicals original product information

Published experimental findings depend on the model and assay conditions. They do not guarantee equivalent performance in every application. For laboratory research use only.

Product documentation

View online datasheetRequest COA / MSDS

Refer to the certificate supplied with your lot for batch-specific release results.

Handling guide

2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Solution calculator

Related research products

SAR407899 chemical structureDC9854

SAR407899

SAR407899 is a selective, potent and ATP-competitive ROCK inhibitor, with an IC50 of 135 nM for ROCK-2, and Kis of 36 nM and 41 nM for human and rat ROCK-2, respectively.

View activity & prices
RKI-1313 chemical structureDC8831

RKI-1313

RKI-1313 is the negative control for RKI-1447 which is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer

View activity & prices
RKI-1447 chemical structureDC7269

RKI-1447

RKI-1447 is a potent small molecule inhibitor of ROCK1 and ROCK2 with IC50 values of 14.5 nM and 6.2 nM, respectively.

View activity & prices
Y-27632 chemical structureDC45762

Y-27632

Y-27632 is an ATP-competitive inhibitor of ROCK-I and ROCK-II, with Ki of 220 nM and 300 nM for ROCK-I and ROCK-II, respectively.

View activity & prices

Cart

Request quotation